Navigation Links
Analysis of Ulcerative Colitis (UC) Time to Symptom Resolution Data from Pivotal Study of LIALDA(TM) (mesalamine) Presented at DDW
Date:5/20/2008

when treating patients with pyloric stenosis or those allergic to sulfasalazine. Mesalamine has been associated with an acute intolerance syndrome (3 percent of patients in clinical trials with mesalamine or sulfasalazine) that may be difficult to distinguish from a flare of inflammatory bowel disease. If acute intolerance syndrome is suspected, prompt withdrawal is required.

Mesalamine-induced cardiac hypersensitivity reactions (myocarditis and pericarditis) have been reported. Reports of renal impairment have been associated with mesalamine medications. In patients with renal impairment, caution should be exercised, and LIALDA should be used only if the benefits outweigh the risks. No information is available for patients with hepatic impairment.

LIALDA is generally well tolerated. The majority of adverse events in the double-blind, placebo-controlled trials were mild or moderate in severity. In clinical trials (n=535), the most common treatment-related adverse events with LIALDA 2.4g/day, 4.8g/day and placebo were headache (5.6 percent, 3.4 percent and 0.6 percent, respectively) and flatulence (4 percent, 2.8 percent and 2.8 percent, respectively). Pancreatitis occurred in less than 1 percent of patients during clinical trials and resulted in discontinuation of therapy with LIALDA.

For more information about LIALDA and for Full Prescribing Information, please visit http://www.LIALDA.com.

About LIALDA

LIALDA is part of a drug class called aminosalicylates, which contain 5- aminosalicyclic acid (5-ASA). 5-ASA is a well-established drug of choice and often a first-line treatment for UC. LIALDA is indicated for the induction of remission in patients with active, mild to moderate UC. The safety and efficacy of LIALDA have been established for up to eight weeks. LIALDA is the first new formulation in this class to be approved since 2000. LIALDA is the only ulcerative colitis treatment
'/>"/>

SOURCE Shire plc
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis
2. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
3. New Data From Large Safety Analysis of MYCAMINE Shows Favorable Clinical Safety Profile
4. Immtech Announces Interim Analysis in Phase III African Sleeping Sickness Trial
5. Analysis Shows Vernakalant Hydrochloride Injection Increases Conversion to Normal Heart Rhythm in Acute Atrial Fibrillation Patients Treated Within 48 Hours of Onset
6. New Analysis of Study Data Shows That Asacol(R) (Mesalamine) Delivers Rapid Symptom Relief for Ulcerative Colitis Patients
7. A Sociolinguistic Analysis of In-Office Dialogue Reveals Psychiatrists and Parents Have Significantly Different Perceptions on ADHD and Psychiatric Comorbidities
8. Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial; Reports Third Quarter 2007 Financial Results
9. Results Of VYVANSE(TM) (lisdexamfetamine dimesylate) Effect Size Analysis Presented at Major Scientific Meeting
10. Progen Presents Additional Analysis of Data from PI-88 Phase 2 Liver Cancer Study at American Association for the Study of Liver Diseases
11. Retrospective Analysis Finds That Initiation of Insulin Glargine in Patients With Type 2 Diabetes was Associated With a Lower Incidence Rate of Myocardial Infarction as Compared With NPH Insulin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... DUBLIN , Aug. 28, 2015 ... announced the addition of the "Investigation Report on ... Developed by Roche under the trade name ... in the world. In Feb.26, 2010, it was approved ... injections available in China all ...
(Date:8/28/2015)... 2015 Research and Markets ... "Investigation Report on China,s Tobramycin Market, 2010-2019" ... traditional antibiotic whose eye drop and ointment are the ... infection or inflammation caused by eye infection. Currently, dozens ... able to produce tobramycin, among which the Top 5 ...
(Date:8/28/2015)... 28, 2015 Patterson Medical, formerly the ... PDCO ), is now an independent company with ... Patterson Medical by Madison Dearborn Partners (MDP).  ... for a transition period before rebranding as the ... medicine products.  With the focused resources and expertise ...
Breaking Medicine Technology:Investigation Report on China's Bevacizumab Market 2015-2019 2Investigation Report on China's Tobramycin Market, 2015-2019 2Patterson Medical Positioned for Continued Growth as a Newly Independent Company 2Patterson Medical Positioned for Continued Growth as a Newly Independent Company 3
... 3 Mach 7 Technologies (M7T), a global provider of ... tools to its flagship Keystone Suite Enterprise Image Management Platform.  The ... Study Split Utility (SSU), and the Keystone Study Import - Export ... , ...
... Asymchem Laboratories announces the hiring of Dr. ... June 1, 2010 .  Dr. Zhang is an expert in ... he worked for 10 years for Wyeth at Rouse,s Point, ... Plant Process Engineering.  He has additional experience as an R&D ...
Cached Medicine Technology:Mach 7 Technologies Rolls Out Keystone Study Segmentation, Rapid Migration and Import - Export Utilities 2Mach 7 Technologies Rolls Out Keystone Study Segmentation, Rapid Migration and Import - Export Utilities 3Mach 7 Technologies Rolls Out Keystone Study Segmentation, Rapid Migration and Import - Export Utilities 4
(Date:8/28/2015)... ... August 28, 2015 , ... ... at the Zoo to celebrate children helping children, a thank you to the ... West Ohio have contributed to the United Methodist initiative to end malaria deaths. ...
(Date:8/28/2015)... ... August 28, 2015 , ... ... Understanding the FDA’s Position and Best Practices for Compliance, **Presented by FDAnews ... This workshop, chaired by internationally renowned expert Fubin Wu, has been specifically ...
(Date:8/28/2015)... (PRWEB) , ... August 28, 2015 , ... ... 20 grams of high grade protein with zero fat, carbs, sugar, gluten, lactose ... been named a finalist for the 2015 SupplySide CPG Editor’s Choice Awards. , ...
(Date:8/28/2015)... ... 28, 2015 , ... The Nashville Business Journal recently announced ... business. Mr. Troy Mizell, Chairman of the Board at MyGenetx, is one ... Veterans Awards will recognize Nashville military veterans who, through their professional and personal ...
(Date:8/28/2015)... CA (PRWEB) , ... August 28, 2015 , ... ... price on Zoom teeth whitening. For just $199, patients can currently receive a one ... traditional in-office teeth whitening procedures, but it includes a number of unique features that ...
Breaking Medicine News(10 mins):Health News:Saturday’s United Methodist Event at Columbus Zoo Celebrates Imagine No Malaria 2Health News:Saturday’s United Methodist Event at Columbus Zoo Celebrates Imagine No Malaria 3Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 2Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 3Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 4Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 5Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 2Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 3Health News:MyGenetx Board Member Receives Veterans Award 2Health News:Northridge Dentists Dr. Elyson and Dr. Assili Now Offer a Special Promotion on Zoom Teeth Whitening 2
... to dispel misinformation, educate women , FRIDAY, Sept. ... about all of the pain management options available to ... Society of Anesthesiologists (ASA). , Over the past three ... delivery pain control, Dr. Craig Palmer, chairman of the ...
... use of phthalates, but industry says hazard isn,t proven, ... the tongue-twisting name of phthalates (pronounced THAL ates) are ... soaps, lotion and cosmetics to plastics and toys. , ... as the Environmental Working Group began to focus on ...
... , GAINESVILLE, Va., Sept. 4 TrueShred ... the highest level of certification awarded by NAID for ... Information Destruction) is the international trade association for companies ... "Achieving NAID Certification confirms the security of ...
... Large Majority of Seniors Fear Negative Impact on Care if Congress ... Help Preserve, Protect and Defend Quality Nursing Home Care ... As Congress prepares to reconvene next week following an August ... care reform, new polling finds both seniors and the public at ...
... NEWPORT BEACH, Calif., Sept. 4 Nationwide Health Properties (NYSE: ... Officer, Abdo Khoury, will participate on a healthcare real estate panel ... on Friday, September 11, 2009 beginning at 7:30 a.m. CDT. , ... live audio-webcast, please us the following link: http://www.bmocm.com/conferences/NARealEstate2009/Webcasts/ ...
... , TEDA TIANJIN, China, Sept. ... subsidiary of Asymchem Laboratories Inc., a leading research-based contract manufacturer ... industry, is pleased to issue the final confirmed list of ... in Asymchem Life Science in TEDA Tianjin, P.R. China, from ...
Cached Medicine News:Health News:Moms-to-Be Need Facts on Pain Control 2Health News:In Toys and More, Are Chemicals Safe or Harmful? 2Health News:In Toys and More, Are Chemicals Safe or Harmful? 3Health News:As August Congressional Recess Concludes, Polls Show Seniors, General Public Strongly Opposed to Medicare Cuts in Congressional Health Reform Plan, Says AHCA 2Health News:As August Congressional Recess Concludes, Polls Show Seniors, General Public Strongly Opposed to Medicare Cuts in Congressional Health Reform Plan, Says AHCA 3Health News:Asymchem Announces Fall Process Symposium Confirmed List of Speakers 2Health News:Asymchem Announces Fall Process Symposium Confirmed List of Speakers 3Health News:Asymchem Announces Fall Process Symposium Confirmed List of Speakers 4
Pefakit in-TDT Calibrators and Controls...
PT-HS with Calcium - 2 ml...
Plasma Control Level 1 - 1 ml...
The ACE Alera clinical chemistry system serves a wide variety of chemistry diagnostic needs with the power of a large floor model analyzer in an easily integrated and economizing compact footprint of...
Medicine Products: